We have successfully applied this technology and launched the first Aquila Bioscience product, “ABD device”. It is free from alcohol and toxic chemicals, and is a biodegradable Class I device that safely captures, removes and neutralizes harmful pathogens and viral infections like coronavirus from the skin including eyes nose and mouth plus sensitive and hard surfaces such as screens, workbenches, desks etc.
Our experienced R&D team bring together a range of science disciplines, bridging Glycobiology, Immunology, Microbiology, biochemistry and analytical chemistry.
Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 9, 2020 | €30m EU Funding For Irish Startups | Eight Irish startups will share more than €30m in funding from the EU’s Horizon 2020 Fund. They join 72 European startups and SMEs awarded €314m to support their development. Among the successful Irish applicants are seven Enterprise Irelan... |
Reviews 0
FAQ about Aquila Bioscience
When was Aquila Bioscience founded?
Aquila Bioscience was founded in 2012.
What has the press written about Aquila Bioscience?
Parsers VC has collected 2 articles mentioning Aquila Bioscience, among them “€30m EU Funding For Irish Startups” (Jun 9, 2020).
Is Aquila Bioscience still active?
Yes, Aquila Bioscience is active; its latest activity on Parsers VC dates from Jan 13, 2025.